Binance Coin Hits $855 on $520M Windtree Investment, 6.3% 24-Hour Gain

Binance Coin (BNB) surged to an unprecedented $855 on July 28, 2025, fueled by a $520 million commitment from biotech firm Windtree Therapeutics to acquire the cryptocurrency as part of its treasury strategy [1]. The price spike marked a pivotal moment for BNB, driven by robust institutional demand, heightened trading activity, and growing confidence in blockchain-based assets. Windtree’s investment, facilitated through a Common Stock Purchase Agreement with ELOC and an additional $20 million deal with Build and Build Corp., underscores a shift toward crypto integration in corporate treasury management [1].

Windtree Therapeutics plans to allocate 99% of net proceeds from these agreements to accumulate BNB, pending shareholder approval for ELOC-related funds [1]. The company’s CEO, Jed Larkin, emphasized a strategic focus on blockchain adoption, with plans to expand facilities for future BNB acquisitions. This approach aligns with Windtree’s vision to leverage blockchain technology for long-term innovation and value creation for shareholders [1].

The price breakout followed BNB’s clean breach of a six-month resistance channel, with $780 serving as a new support level. Key metrics highlighted the momentum: a 24-hour gain of 6.3%, a 12.7% increase over seven days, and a 194.5% surge in 24-hour trading volume to $2.9 billion. BNB’s market capitalization reached $118 billion, solidifying its position as a top cryptocurrency. Analysts attributed the rally to sustained institutional inflows and on-chain activity, including tripled transactions since April and stablecoin inflows exceeding $11 billion [1].

Forecasts from industry experts project BNB could reach $1,000 by Q4 2025, with cycle peak estimates ranging between $1,800 and $2,000. These projections are tied to BNB’s accumulation phases, such as over 120,000 tokens accumulated by Nano Labs, and its emergence as a “growth phase” asset backed by Binance’s ecosystem dominance. BitBull Capital noted the coin’s robust fundamentals and expanding blockchain infrastructure as key drivers [1].

Windtree’s investment reflects a broader trend of institutional adoption in the crypto sector. By allocating a significant portion of its capital to BNB, the biotech firm aims to diversify its treasury while aligning with blockchain innovation. This move also signals confidence in Binance’s network, which remains a global leader in trading volume and user base [1].

The partnership highlights the growing intersection between traditional finance and blockchain, as corporations explore digital assets to enhance liquidity and long-term value. With BNB’s price trajectory supported by treasury demand and technical indicators, the market is closely watching for further institutional commitments that could reinforce its bullish outlook [1].

Source: [1] BNB Hits All-Time High of $855 After Windtree Therapeutics Commits $520M [https://coinmarketcap.com/community/articles/688851894b2f3f471eb491b0/]